Format

Send to

Choose Destination
Am J Nephrol. 2004 Jan-Feb;24(1):46-53. Epub 2003 Dec 30.

Cellular lipid metabolism and the role of lipids in progressive renal disease.

Author information

1
Department of Medicine, University of Washington School of Medicine, Seattle, Wash. 98108, USA. cabrass@u.washington.edu

Abstract

Dyslipidemia contributes to the rate of progression of atherosclerosis and chronic kidney disease. Also, chronic kidney disease leads to the development of secondary abnormalities in lipid metabolism that contribute to increased cardiovascular morbidity and mortality. This review presents the mechanisms that underlie this risk. The mechanisms of normal cellular lipid metabolism and the abnormalities that develop in association with inflammation are reviewed. There is a special emphasis on foam cells in the kidney and on lipid-mediated changes in intrinsic kidney cells that lead to glomerulosclerosis and interstitial fibrosis. Correlates to studies performed in whole animals and humans are included.

PMID:
14707435
DOI:
10.1159/000075925
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for S. Karger AG, Basel, Switzerland
Loading ...
Support Center